{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:10:33Z","timestamp":1739509833779,"version":"3.37.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,12]]},"DOI":"10.7759\/cureus.78923","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T06:08:21Z","timestamp":1739426901000},"source":"Crossref","is-referenced-by-count":0,"title":["A Population-Based Cohort Study on the Association Between Oral Third-Generation Cephalosporins and Other Antimicrobial Prescriptions and Adverse Events: Findings From the Shizuoka Kokuho Database Study"],"prefix":"10.7759","author":[{"given":"Hisashi","family":"Dote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daito","family":"Funaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanako","family":"Ubukata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Miyakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Ohata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Imaichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Shoji-Asahina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0348-5","article-title":"Resisting antimicrobial resistance","volume":"18","author":"Nathan C","year":"2020","unstructured":"Nathan C. Resisting antimicrobial resistance. Nat Rev Microbiol. 2020, 18:259-60. 10.1038\/s41579-020-0348-5","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.04.005","article-title":"Antimicrobial resistance: an antimicrobial\/diagnostic stewardship and infection prevention approach","volume":"102","author":"Septimus EJ","year":"2018","unstructured":"Septimus EJ. Antimicrobial resistance: an antimicrobial\/diagnostic stewardship and infection prevention approach. Med Clin North Am. 2018, 102:819-29. 10.1016\/j.mcna.2018.04.005","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-019-01362-x","article-title":"Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins","volume":"47","author":"Uda A","year":"2019","unstructured":"Uda A, Kimura T, Nishimura S, et al.. Efficacy of educational intervention on reducing the inappropriate use of oral third-generation cephalosporins. Infection. 2019, 47:1037-45. 10.1007\/s15010-019-01362-x","journal-title":"Infection"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2016.07.002","article-title":"Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009-2013)","volume":"7","author":"Muraki Y","year":"2016","unstructured":"Muraki Y, Yagi T, Tsuji Y, et al.. Japanese antimicrobial consumption surveillance: first report on oral and parenteral antimicrobial consumption in Japan (2009-2013). J Glob Antimicrob Resist. 2016, 7:19-23. 10.1016\/j.jgar.2016.07.002","journal-title":"J Glob Antimicrob Resist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.11.009","article-title":"Indications and classes of outpatient antibiotic prescriptions in Japan: a descriptive study using the national database of electronic health insurance claims, 2012-2015","volume":"91","author":"Hashimoto H","year":"2020","unstructured":"Hashimoto H, Saito M, Sato J, et al.. Indications and classes of outpatient antibiotic prescriptions in Japan: a descriptive study using the national database of electronic health insurance claims, 2012-2015. Int J Infect Dis. 2020, 91:1-8. 10.1016\/j.ijid.2019.11.009","journal-title":"Int J Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41393-020-0416-8","article-title":"Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit","volume":"58","author":"Kitagawa K","year":"2020","unstructured":"Kitagawa K, Shigemura K, Nomi M, Takami N, Yamada N, Fujisawa M. Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit. Spinal Cord. 2020, 58:705-10. 10.1038\/s41393-020-0416-8","journal-title":"Spinal Cord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10111426","article-title":"Effect of antimicrobial stewardship on oral quinolone use and resistance patterns over 8 years (2013-2020)","volume":"10","author":"Uda A","year":"2021","unstructured":"Uda A, Shigemura K, Kitagawa K, et al.. Effect of antimicrobial stewardship on oral quinolone use and resistance patterns over 8 years (2013-2020). Antibiotics (Basel). 2021, 10:1426. 10.3390\/antibiotics10111426","journal-title":"Antibiotics (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/107662903764736337","article-title":"Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States","volume":"9","author":"Hasegawa K","year":"2003","unstructured":"Hasegawa K, Yamamoto K, Chiba N, et al.. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb Drug Resist. 2003, 9:39-46. 10.1089\/107662903764736337","journal-title":"Microb Drug Resist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05929-3","article-title":"Antimicrobial-associated harm in critical care: a narrative review","volume":"46","author":"Arulkumaran N","year":"2020","unstructured":"Arulkumaran N, Routledge M, Schlebusch S, Lipman J, Conway Morris A. Antimicrobial-associated harm in critical care: a narrative review. Intensive Care Med. 2020, 46:225-35. 10.1007\/s00134-020-05929-3","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2020.1400","article-title":"Association between extended-spectrum \u03b2-lactamase-producing Escherichia coli and oral third-generation cephalosporins","volume":"43","author":"Hosokawa H","year":"2022","unstructured":"Hosokawa H, Mitsuboshi S, Isobe H, Kobayashi K, Moro H, Kikuchi T. Association between extended-spectrum \u03b2-lactamase-producing Escherichia coli and oral third-generation cephalosporins. Infect Control Hosp Epidemiol. 2022, 43:261-3. 10.1017\/ice.2020.1400","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199507050-00006","article-title":"Clinical and economic considerations in the use of third-generation oral cephalosporins","volume":"7","author":"Chambers ST","year":"1995","unstructured":"Chambers ST, Murdoch DR, Pearce MJ. Clinical and economic considerations in the use of third-generation oral cephalosporins. Pharmacoeconomics. 1995, 7:416-27. 10.2165\/00019053-199507050-00006","journal-title":"Pharmacoeconomics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20200480","article-title":"Data resource profile of Shizuoka Kokuho Database (SKDB) using integrated health- and care-insurance claims and health checkups: the Shizuoka study","volume":"32","author":"Nakatani E","year":"2022","unstructured":"Nakatani E, Tabara Y, Sato Y, Tsuchiya A, Miyachi Y. Data resource profile of Shizuoka Kokuho Database (SKDB) using integrated health- and care-insurance claims and health checkups: the Shizuoka study. J Epidemiol. 2022, 32:391-400. 10.2188\/jea.JE20200480","journal-title":"J Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe C","year":"2010","unstructured":"Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010, 340:c2096. 10.1136\/bmj.c2096","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan H","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, et al.. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005, 43:1130-9. 10.1097\/01.mlr.0000182534.19832.83","journal-title":"Med Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-01035-6","article-title":"Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition","volume":"46","author":"Pugliese G","year":"2022","unstructured":"Pugliese G, Liccardi A, Graziadio C, Barrea L, Muscogiuri G, Colao A. Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. Int J Obes (Lond). 2022, 46:449-65. 10.1038\/s41366-021-01035-6","journal-title":"Int J Obes (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab091","article-title":"Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update","volume":"76","author":"Slimings C","year":"2021","unstructured":"Slimings C, Riley TV. Antibiotics and healthcare facility-associated Clostridioides difficile infection: systematic review and meta-analysis 2020 update. J Antimicrob Chemother. 2021, 76:1676-88. 10.1093\/jac\/dkab091","journal-title":"J Antimicrob Chemother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2016.03.008","article-title":"Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis","volume":"48","author":"Vardakas KZ","year":"2016","unstructured":"Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016, 48:1-10. 10.1016\/j.ijantimicag.2016.03.008","journal-title":"Int J Antimicrob Agents"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3201\/eid1307.061561","article-title":"Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom","volume":"13","author":"Schneider-Lindner V","year":"2007","unstructured":"Schneider-Lindner V, Delaney JA, Dial S, Dascal A, Suissa S. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis. 2007, 13:994-1000. 10.3201\/eid1307.061561","journal-title":"Emerg Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir840","article-title":"Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia","volume":"54","author":"Aliberti S","year":"2012","unstructured":"Aliberti S, Di Pasquale M, Zanaboni AM, et al.. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis. 2012, 54:470-8. 10.1093\/cid\/cir840","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2020-216029","article-title":"Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis","volume":"76","author":"Carrillo-Larco RM","year":"2022","unstructured":"Carrillo-Larco RM, Anza-Ram\u00edrez C, Saal-Zapata G, Villarreal-Zegarra D, Zafra-Tanaka JH, Ugarte-Gil C, Bernab\u00e9-Ortiz A. Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis. J Epidemiol Community Health. 2022, 76:75-84. 10.1136\/jech-2020-216029","journal-title":"J Epidemiol Community Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00067-7","article-title":"Infective endocarditis","volume":"387","author":"Cahill TJ","year":"2016","unstructured":"Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016, 387:882-93. 10.1016\/S0140-6736(15)00067-7","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults","volume":"61","author":"Berbari EF","year":"2015","unstructured":"Berbari EF, Kanj SS, Kowalski TJ, et al.. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis. 2015, 61:e26-46. 10.1093\/cid\/civ482","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281518","article-title":"Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: an interrupted time-series analysis","volume":"18","author":"Itoh N","year":"2023","unstructured":"Itoh N, Kawabata T, Akazawa N, et al.. Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: an interrupted time-series analysis. PLoS One. 2023, 18:e0281518. 10.1371\/journal.pone.0281518","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra I","year":"2001","unstructured":"Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001, 65:232-60. 10.1128\/MMBR.65.2.232-260.2001","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix833","article-title":"Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and metaanalysis","volume":"66","author":"Tariq R","year":"2018","unstructured":"Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi DS, Khanna S. Low risk of primary Clostridium difficile infection with tetracyclines: a systematic review and metaanalysis. Clin Infect Dis. 2018, 66:514-22. 10.1093\/cid\/cix833","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.11.001","article-title":"The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy","volume":"25","author":"Maeda M","year":"2019","unstructured":"Maeda M, Muraki Y, Kosaka T, et al.. The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy. J Infect Chemother. 2019, 25:83-8. 10.1016\/j.jiac.2018.11.001","journal-title":"J Infect Chemother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam TF","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, et al.. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016, 62:e51-77. 10.1093\/cid\/ciw118","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/329328-a-population-based-cohort-study-on-the-association-between-oral-third-generation-cephalosporins-and-other-antimicrobial-prescriptions-and-adverse-events-findings-from-the-shizuoka-kokuho-database-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T06:08:23Z","timestamp":1739426903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/329328-a-population-based-cohort-study-on-the-association-between-oral-third-generation-cephalosporins-and-other-antimicrobial-prescriptions-and-adverse-events-findings-from-the-shizuoka-kokuho-database-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.78923","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,12]]}}}